Rising Tides in Japan: The Bank of Japan’s Shift and its Impact on the Markets The BoJ’s Policy Evolution Amid rising concerns about inflation, the Bank of Japan (BoJ) has signaled a strategic departure from its long-standing policy. A closer examination reveals the implications of this move for Japan’s economy, the financial markets, and potential…
The Fed Leaves Interest Rates Unchanged: What Does This Mean? Yesterday, the Fed left interest rates unchanged as expected with basically no change to the policy statement. Fed Chair Powell repeated once again that they are “proceeding carefully” as the full effects of the policy tightening have yet to be felt. There were some expectations…
Investor Alert: Abbott Cooper PLLC Investigates Medifast, Inc. Stamford, Conn., Nov. 02, 2023 (GLOBE NEWSWIRE) Abbott Cooper PLLC is investigating Medifast, Inc. (NYSE: MED) (“Medifast” or the “Company”) on behalf of the Company’s investors. The investigation seeks to determine whether Medifast’s board of directors (the “Board”) has violated its fiduciary duty by instituting measures intended…
Investor Alert: Abbott Cooper PLLC Investigates Sight Sciences, Inc. STAMFORD, Conn., Nov. 02, 2023 (GLOBE NEWSWIRE) — Abbott Cooper PLLC is currently investigating Sight Sciences, Inc. (Nasdaq: SGHT) on behalf of the Company’s investors. This investigation is aimed at determining whether the board of directors at Sight Sciences has breached their fiduciary duty by implementing…
Investors Urged to Seek Legal Assistance Following Tandem Diabetes Care Lawsuit LOS ANGELES, Nov. 01, 2023 (GLOBE NEWSWIRE) — The Portnoy Law Firm has recently advised Tandem Diabetes Care, Inc. investors about a lawsuit filed on behalf of individuals who purchased Tandem securities during a specified period. The lawsuit aims to help investors recover potential…
Corvus Pharmaceuticals Announces Publication of Preclinical Data Demonstrating Potential of Soquelitinib Data demonstrated soquelitinib was active in six inflammatory/immune disease models and provides rationale for development in a range of additional Th2- and Th17-mediated diseases Corvus Pharmaceuticals has recently announced the publication of preclinical data showcasing the promising potential of their drug, Soquelitinib. The data…
Welcome to the Rosen Law Firm Blog! Don’t Miss the November 14, 2023 Deadline for Lumen Technologies, Inc. Investors Hey there, fellow investors! If you’ve had your eye on Lumen Technologies, Inc. (NYSE: LUMN) between March 11, 2019 and July 14, 2023, then listen up – because we’ve got some important news for you. The…
Welcome to the Park Hotels & Resorts Inc. Third Quarter 2023 Update! Financial Highlights It’s that time of year again – the Park Hotels & Resorts Inc. has released its results for the third quarter of 2023! And boy, do we have some exciting news to share. The Company reported strong financial metrics, with a…
